Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Search Over For New Chief For England’s NICE

Samantha Roberts Will Lead The Powerful HTA Body

Executive Summary

NICE, which is seen as a global leader when it comes to assessing the clinical and cost effectiveness of health care products, has appointed Samantha Roberts as its third chief executive in its over 20-year history.

You may also be interested in...



England’s NICE To Find New Chief As Leng Announces Retirement

The top job at the National Institute for Health and Care Excellence has been described as one of the most challenging and potentially controversial roles in British public life.

Last Chance To Influence Changes To NICE Methods & Processes In England

Companies selling gene therapies and other high-cost, long-term treatments may be disappointed but unsurprised to learn that NICE will not immediately introduce any change to discount rates, which are used in health technology appraisals to better understand the long-term costs and benefits.

Sir Andrew Dillon Standing Down As Head Of England’s NICE After 20 Years

Sir Andrew Dillon is stepping down from what has been described as one of the most challenging and potentially controversial roles in British public life.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS145430

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel